Johanna Maffey-Steffan

68Ga-PSMA-11 PET/CT in primary staging of prostate cancer: PSA and Gleason score predict the intensity of tracer accumulation in the primary tumour

Christian Uprimny, Alexander Kroiss, Clemens Decristoforo et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2017 · 342 citations

Medicine, Nuclear Medicine, Oncology +17

Prior therapies as prognostic factors of overall survival in metastatic castration-resistant prostate cancer patients treated with [177Lu]Lu-PSMA-617. A WARMTH multicenter study (the 617 trial)

Hojjat Ahmadzadehfar, Kambiz Rahbar, Richard P. Baum et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2020 · 129 citations · Full text

Medicine, Oncology, Pharmacology +17

The 68Ga/177Lu-theragnostic concept in PSMA-targeting of metastatic castration–resistant prostate cancer: impact of post-therapeutic whole-body scintigraphy in the follow-up

Johanna Maffey-Steffan, Lorenza Scarpa, Anna Svirydenka et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2019 · 56 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Early PET imaging with [68]Ga-PSMA-11 increases the detection rate of local recurrence in prostate cancer patients with biochemical recurrence

Christian Uprimny, Alexander Kroiss, Josef Fritz et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2017 · 54 citations

Medicine, Nuclear Medicine, Oncology +17

Radiation exposure after 177Lu-DOTATATE and 177Lu-PSMA-617 therapy

Christian Mair, Boris Warwitz, Katharina Fink et al. · Annals of Nuclear Medicine · 2018 · 21 citations

Medicine, Nuclear Medicine, Oncology +14